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EphA Receptors Regulate Growth Cone Dynamics
through the Novel Guanine Nucleotide
Exchange Factor Ephexin
specific cell surface receptors to control axon guidance.
These guidance factors function as either attractive or
repulsive guidance cues depending on their ability to
induce growth cone extension or retraction. The direc-
tional control of axon pathfinding is thought to result
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to provide precise control of axon guidance during ner-Stanford University
vous system development.Fairchild D249
We have addressed this question for a set of guidanceSUMC
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tors bind the transmembrane ephrin-B ligands. Eph re-115 Mill Street
ceptors and ephrins are required for the proper forma-Belmont, Massachusetts 02478
tion of specific axon projections in the central nervous
system, including the corticospinal tract and the anterior
commissure (reviewed in Frisen et al., 1999). The roleSummary
of Eph receptors in axon guidance has been most thor-
oughly characterized in the chick retinotectal projection,Eph receptors transduce short-range repulsive signals
where gradients of expression of EphA receptors andfor axon guidance by modulating actin dynamics within
ligands are necessary for proper topographic mappinggrowth cones. We report the cloning and character-
(reviewed in Flanagan and Vanderhaeghen, 1998). Ephization of ephexin, a novel Eph receptor-interacting
receptors and ephrins also restrict cell migration duringprotein that is a member of the Dbl family of guanine
hindbrain segmentation and vasculogenesis, possiblynucleotide exchange factors (GEFs) for Rho GTPases.
via modulation of integrin function (reviewed in Wilkin-Ephrin-A stimulation of EphA receptors modulates the
son, 2001).activity of ephexin leading to RhoA activation, Cdc42
The control of axon guidance by Eph receptors isand Rac1 inhibition, and cell morphology changes. In
believed to be mediated by alterations in actin dynamicsaddition, expression of a mutant form of ephexin in pri-
that lead to growth cone retraction. However, the intra-mary neurons interferes with ephrin-A-induced growth
cellular mechanisms involved in coupling Eph receptorcone collapse. The association of ephexin with Eph
activation to changes in the actin cytoskeleton havereceptors constitutes a molecular link between Eph
remained unresolved. The various members of the p21receptors and the actin cytoskeleton and provides a
Rho family of small guanosine triphosphatases (GTPases)novel mechanism for achieving highly localized regu-
elicit distinct effects on actin structures (Schmitz et al.,
lation of growth cone motility.
2000) and are likely to be involved in Eph receptor regula-
tion of the actin cytoskeleton. In neuronal cell lines, the
Introduction activation of the Rho family GTPase RhoA stimulates
actinomyosin contractility and stress fiber formation re-
The pathfinding of axons during the development of the sulting in growth cone collapse, whereas the induction
nervous system is a highly regulated process governed of Cdc42 and Rac1 results in the extension of filopodia
by a complex set of environmental guidance cues. A num- and lamellipodia, respectively (Kozma et al., 1997). Re-
ber of extracellular factors have been identified, including cently, Eph receptor activation has been linked to
netrins, slits, semaphorins, and ephrins, that act through changes in the activities of certain Rho GTPases (Wahl
et al., 2000). The activation of EphA receptors in retinal
5 To whom correspondence should be addressed: (e-mail: greenberg@ ganglion cells (RGCs) induced the activation of RhoA
a1.tch.harvard.edu).
and the inhibition of Rac1, consistent with a retraction6 These authors contributed equally to the work and are listed in
response. Thus, Eph receptors may control growth conerandom order.
motility by regulating the balance between the activities7 These authors contributed equally to the work and are listed in
random order. of individual Rho GTPases.
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The molecular mechanisms by which EphA receptors nucleotide 156. More recently, a partial cDNA encoding
mouse ephexin, called Ngef, was identified and wasand other axon guidance receptors regulate the activity
of Rho family GTPases remain to be elucidated. It is demonstrated to reside on human chromosome 2q37
and mouse chromosome 1 (Rodrigues et al., 2000).known that Rho GTPases function as binary molecular
switches, shuttling between an inactive GDP bound con- Conceptual translation of the mouse cDNA revealed
a protein of 620 amino acids comprising an N-terminalformation and an active GTP bound conformation, in
which the Rho GTPases bind and activate downstream region with no homology to other proteins, a tandem
Dbl homology-pleckstrin homology (DH-PH) motif thateffectors. Rho GTPases are regulated by the opposing
effects of two classes of enzymes, guanine nucleotide is conserved in all Dbl GEFs, and a C-terminal SH3
domain (Figure 1A). Immunoblotting with affinity-puri-exchange factors (GEFs) of the Dbl family and GTPase-
activating proteins (GAPs). Dbl GEFs act to enhance the fied polyclonal antibodies raised against either the
N-terminal region, the SH3 domain, or the C-terminalexchange of bound GDP for GTP and thus activate the
Rho GTPases, whereas GAPs inhibit Rho family mem- tail of ephexin detected an endogenous protein present
in rat telencephalic neurons (Figure 1B) that displayedbers by potentiating their intrinsic GTPase activity. One
intriguing possibility is that the activity of Dbl GEFs the same electrophoretic mobility as recombinant mu-
rine ephexin expressed in 293T cells (data not shown).and/or GAPs might be regulated by cell surface recep-
tors so as to link extracellular axon guidance cues to Partial V8 proteolysis of lysates from neurons and
ephexin-expressing 293T cells followed by immunoblot-highly localized changes in the actin cytoskeleton within
a growth cone. ting with the C-terminal anti-ephexin antibody confirmed
that the recombinant and endogenous proteins are iden-Here we report the cloning and characterization of
ephexin, a novel member of the Dbl family of GEFs that tical (data not shown). Taken together, these data indi-
cate that the murine ephexin clone includes the full-interacts directly with EphA4. In the absence of ephrin-
A stimulation, ephexin catalyzes guanine nucleotide ex- length ephexin coding sequence.
The initiator methionine of ephexin is followed by achange for RhoA, Cdc42, and Rac1. The activation of
EphA receptors inhibits ephexin activity toward Cdc42 hydrophobic stretch of 14 amino acids resembling a
signal peptide or a signal-anchor sequence (Martoglioand Rac1, yet potentiates its activity toward RhoA. An
inhibitory mutant of ephexin suppresses ephrin-A1- and Dobberstein, 1998). We have been unable to detect
endogenous or overexpressed rat ephexin in a secretedinduced growth cone collapse in purified RGCs, sug-
gesting an important role for ephexin in EphA regulation form, and the hydrophobic sequence is not predicted
to be a signal peptide by an algorithm designed to recog-of growth cone motility. We propose that spatially re-
stricted regulation of Rho GTPase signaling pathways nize signal peptides (Emanuelsson et al., 2000). Instead,
this hydrophobic region may serve as a signal-anchorthrough the modulation of ephexin activity may underlie
localized growth cone responses to ephrin-A. sequence to localize ephexin to the inner surface of the
plasma membrane (Wahlberg and Spiess, 1997). Immu-
noblotting of cellular membranes from postnatal day 7Results
(P7) rat brain revealed that ephexin is present both in
detergent-soluble cytoplasmic fractions and detergent-Cloning of Ephexin, A Novel Member of the Dbl
insoluble membrane fractions that contain caveolin (Fig-Family of Guanine Nucleotide Exchange
ure 1B), a marker of membrane-associated caveolae inFactors (GEFs)
which Eph receptors have been detected (Rothberg etTo identify EphA4-interacting proteins that might func-
al., 1992; Wu et al., 1997).tion to regulate axon guidance, we performed a yeast
Ephexin-related genes were found to be present intwo-hybrid screen. The bait construct consisted of the
invertebrates and vertebrates, and their sequences areintracellular portion of mouse EphA4 fused to the DNA
highly conserved, suggesting an essential function forbinding domain of LexA (Finley and Brent, 1996) and
ephexin. The genomes of C. elegans and Drosophilawas autophosphorylated when expressed in yeast (data
each contain a single gene with a high degree of homol-not shown). We obtained 25 independent interacting
ogy to ephexin (Figures 1C and 1D). In humans, in addi-clones upon screening a cDNA library from embryonic
tion to an ephexin ortholog, there are at least threeday 14 (E14) rat spinal cord and dorsal root ganglia. One
other genes that are highly homologous to ephexin—theof the clones encoded a novel member of the Dbl family
previously characterized Dbl family member TIM (Chanof guanine nucleotide exchange factors for Rho family
et al., 1994) and two uncharacterized cDNAs, Neuro-GTPases. We named this gene ephexin, for Eph-inter-
blastoma and KIAA0915. Using the ClustalX program,acting exchange protein.
we performed phylogenetic analysis of the DH-PH do-To determine if the ephexin coding region extends
mains of the ephexin-related proteins and comparedfurther than the 59 end of the cDNA that we initially
them to the DH-PH domains of Dbl and Vav1, two otheridentified, we performed 59-rapid amplification of cDNA
Dbl family GEFs. This analysis revealed that the DH-ends (59-RACE) from rat brain mRNA and obtained an
PH domains of ephexin-related GEFs are more closelyadditional 395 nucleotides of sequence that matched a
related to each other than to the DH-PH domains ofmouse expressed sequence tag (EST). Complete se-
Dbl and Vav1, and identified ephexin-related GEFs as aquencing of the mouse EST revealed 94% identity to
subfamily within the larger Dbl family of GEFs (Figurerat ephexin within the coding region and indicated that
1C). Alignment of ephexin subfamily proteins revealedit likely represents the mouse ortholog of ephexin. The
a high degree of conservation within the DH, PH, andmouse ephexin clone extended the known sequence to
include a consensus Kozak translation initiation site at SH3 domains, but little or no homology in the N-terminal
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Figure 1. Analysis of Ephexin Amino Acid Sequences
(A) Protein sequence and domain structure of mouse ephexin. DH domain, boldface; PH domain, boldface underscored; SH3 domain, boldface
italics. Domains were identified by the program Pfam.
(B) Subcellular fractionation of ephexin. Total cellular membranes from P7 rat brains, the Triton X-100-solubilized membrane fraction, or the
insoluble fraction were analyzed by immunoblotting with antibodies to the SH3 domain (top) or C terminus (middle) of ephexin, or to caveolin
(bottom).
(C) Phylogenetic analysis of the DH-PH cassettes of ephexin and other Dbl family proteins using the program ClustalX. R.n., Rattus norvegicus;
M.m, Mus musculus; H.s., Homo sapiens; C.e., Caenorhabditis elegans; D.m., Drosophila melanogaster.
(D) Comparisons of individual domains of ephexin subfamily proteins by pairwise BLASTP analysis. DH domain, filled box; PH domain, hatched
box; SH3 domain, stippled box. The amino acid positions of the domain boundaries are shown above, and the percent identities to mouse
ephexin are shown underneath.
regions, including the 14 amino acid hydrophobic se- other ages to determine if ephexin expression is devel-
opmentally regulated. Ephexin mRNA can first be detectedquence present in ephexin orthologs (Figure 1D).
in E15 rat brain and gradually increases throughout em-
bryonic development (Figure 2A). In the early postnatal
Ephexin Expression Is Enriched in the Nervous period, ephexin mRNA levels rise sharply, peak at P10,
System and Is Developmentally Regulated and then decline. Interestingly, this expression pattern
We determined the tissue distribution of ephexin to gain closely matches that previously described for EphA4
insight into possible functional roles for this GEF. North- (Mori et al., 1995). Ephexin mRNA expression in the E17
ern blot analysis of ephexin mRNA from P20 rat tissues rat was found by in situ hybridization to be restricted to
revealed an approximately 2.8 kb mRNA species with the eye and also in deep layers of the developing cortex
highest levels of expression in the brain and spinal cord (Figure 2B). In the eye, ephexin expression was diffuse
and lower levels of expression in testes (Figure 2A). In at E17 and then became highly restricted to the inner
addition, we detected low levels of a transcript in kidney nuclear and RGC layers at P6 (Figure 2C). Staining of
and liver that migrates more slowly than the neuronal control and ephexin-transfected P6 RGCs with the affin-
transcripts. These more slowly migrating transcripts may ity-purified polyclonal anti-ephexin N-terminal antibody
represent alternatively spliced or initiated ephexin mRNA (anti-ephexinN) revealed that endogenous and overex-
or a closely related family member. Ephexin mRNA was pressed ephexin protein is localized in RGC axonal
not detected in heart, lung, skeletal muscle, or spleen. growth cones (Figure 2D). Since the topographic map-
The enrichment of ephexin mRNA in the nervous sys- ping of RGC axons to CNS targets in the early postnatal
stages of development is regulated by EphA receptors intem at P20 led us to explore its expression in brain at
Cell
236
Figure 2. Expression Pattern of Ephexin
(A) Northern blot analysis of ephexin mRNA expression. Blots with mRNA from P20 rat tissues (left) or from total rat brain from different ages
(right) were probed with a fragment of rat ephexin corresponding to the PH and SH3 regions.
(B and C) In situ hybridization of ephexin mRNA in rat tissue sections. A sagittal section from an E17 embryo (B) or a coronal section of a P6
eye (C) was probed with the SH3 and 39 untranslated regions of rat ephexin. An adjacent eye section (C, right) was stained with cresyl violet
to identify cell layers. PE, pigmented epithelium; ONL, outer nuclear layer; INL, inner nuclear layer; RGC, retinal ganglion cell layer.
(D) Immunocytochemical staining of ephexin in purified RGCs. Control (left) or ephexin-transfected (right) RGCs were stained with the anti-
ephexinN antibody.
the growth cone (Flanagan and Vanderhaeghen, 1998), shown). These findings indicate that ephexin and EphA4
interact when they are coexpressed in mammalian cells.these findings indicate that ephexin is expressed with
an appropriate spatial and temporal profile to mediate We also tested whether the interaction between
ephexin and EphA4 was dependent on EphA4 tyrosineimportant functional effects of Eph receptors.
phosphorylation. We generated an EphA4 mutant in
which valine 635 in the ATP binding region was con-Interaction and Domain Mapping
between Ephexin and EphA4 verted to a methionine (V635M), rendering EphA4 kinase
inactive (KD) (Shu et al., 1994) (Figure 3A). When ex-The observation that ephexin interacts with the cyto-
plasmic domain of EphA4 in yeast raised the possibility pressed in 293T cells, EphA4-KD is not tyrosine phos-
phorylated (Figure 3A). However, the EphA4-KD mutantthat ephexin and EphA4 interact in mammalian cells.
To test this possibility, we cotransfected 293T cells with was able to interact with ephexin to the same extent
as wild-type EphA4 in both 293T cell coprecipitationephexin and EphA4 expression constructs, and immuno-
precipitated detergent cell lysates with the anti-ephexinN experiments and in the yeast two-hybrid assay (Figures
3A and 3B). These results indicate that ephexin interactsantibody. As shown in Figure 3A, the EphA4 receptor
was readily detected in anti-ephexinN immunoprecipi- with EphA4 receptors in both the absence and presence
of EphA4 receptor autophosphorylation.tates. The coimmunoprecipitation of EphA4 with the
anti-ephexinN antibody was dependent on the expres- We next identified the domain within EphA4 that medi-
ates the interaction with ephexin. EphA4 constructssion of ephexin (Figure 3A) and was undetectable in
immunoprecipitates in which a nonimmune rabbit IgG were generated in which portions of EphA4 were de-
leted. The resulting EphA4 mutants were expressed atantibody replaced the anti-ephexinN antibody (data not
EphA Receptors Regulate Ephexin, a Novel Rho GEF
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Figure 3. Interaction and Domain Mapping between Ephexin and EphA4
(A) Coimmunoprecipitation of ephexin and EphA4 in 293T cells. 293T cells were transfected with ephexin and/or wild-type (WT) or kinase-
dead (KD) EphA4. Two days later, cell lysates were immunoprecipitated with anti-ephexinN and immunoblotted with an anti-EphA4 antibody
(top). Whole-cell lysates were also immunoblotted with anti-EphA4 (middle) or a phosphorylation-specific EphA receptor antibody (anti-P-
EphA, bottom).
(B) Mapping of the ephexin interaction domain of EphA4. Rat ephexin (amino acids 67–620) was coexpressed in the yeast two-hybrid assay
with the LexA DNA binding domain alone or with LexA fusions to the cytoplasmic domain of EphA4, kinase-dead EphA4 (A4-KD), SAM domain-
truncated EphA4 (A4-DSAM), or C-terminal kinase domain truncated EphA4 (A4-DKC), or to the cytoplasmic domain of TrkA. Positive interactions
were indicated by the induction of a LacZ reporter. EphA4 juxtamembrane domain, hatched box; amino-terminal kinase lobe, stippled box;
carboxy-terminal kinase lobe, shaded box; SAM domain, open box; V635M kinase-inactivating mutation, VM; cytoplasmic TrkA domain, black
box.
(C and D) Mapping of the EphA4 interaction domain of ephexin. (C) The EphA4 cytoplasmic domain was coexpressed with the B42 transcription
activation domain alone or with B42 fusions to the indicated domains of ephexin. (D) Coimmunoprecipitation of ephexin domains and EphA4 in
293T cells. Flag-tagged domains of ephexin were cotransfected with EphA4 and the cell lysates immunoprecipitated with anti-Flag antibody
followed by immunoblotting with anti-EphA4 (top left) or anti-Flag (bottom left). Whole-cell lysates were also immunoblotted with anti-EphA4
(top right) or anti-Flag (bottom right).
comparable levels in the yeast two-hybrid assay (data lobe of the EphA4 kinase domain (EphA4-DKC). The
EphA4-DKC mutant failed to interact with ephexin in thenot shown) and tested for their interaction with ephexin.
EphA4 receptors lacking the sterile a motif (SAM) do- yeast two-hybrid assay, indicating that ephexin binds
to specific sequences within the C-terminal lobe of themain in the C-terminal tail thought to mediate homophilic
interactions (EphA4-DSAM) were capable of interacting EphA4 kinase domain (Figure 3B). Ephexin interacts effi-
ciently with multiple EphA receptors but poorly withwith ephexin as effectively as the wild-type receptor,
suggesting that the ephexin interaction domain resides EphB receptors (data not shown) and fails to interact
with TrkA (Figure 3B), another RTK expressed in CNSwithin the EphA4 juxtamembrane or kinase domains
(Figure 3B). To explore a possible interaction between neurons, highlighting the specificity of the EphA4-
ephexin association.ephexin and the tyrosine kinase domain of EphA4, we
used information from the crystal structures of Src family We next investigated which regions of ephexin medi-
ate interaction with EphA4. Since the original yeast two-tyrosine kinases (Sicheri et al., 1997; Xu et al., 1997) to
construct an EphA4 mutant that lacks the C-terminal hybrid interacting clone of ephexin lacked amino-termi-
Cell
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nal sequences, we focused on the DH, PH, and SH3 assays indicate that ephexin strongly activates RhoA
and Cdc42, and may also promote Rac1 activity in cells.domains. The individual ephexin DH, PH, and SH3 do-
mains or the DH-PH combined domains were equiva-
lently expressed (data not shown) and tested in the yeast
Ephexin Activates the Rac1 and Cdc42 Effectortwo-hybrid assay to determine which regions of ephexin
Kinase, Pakwere sufficient to maintain the interaction with EphA4.
Since ephexin has strong GEF activity toward differentThe ephexin DH, PH, or SH3 domains alone were unable
Rho family members, we investigated whether effectorto bind EphA4 in the two-hybrid assay (Figure 3C). How-
enzymes downstream of Rho GTPases might also beever, the tandem ephexin DH-PH domains were suffi-
induced in response to ephexin activation. Several linescient to mediate an interaction with EphA4, suggesting
of evidence link activation of the Rac1 and Cdc42 ef-that portions of both domains are important for the inter-
fector Pak to modifications in the organization of theaction of ephexin with EphA4 (Figure 3C). The domains
actin cytoskeleton (Bagrodia and Cerione, 1999). Toof ephexin that mediate the EphA4-ephexin interaction
monitor Pak activation, we raised a phosphorylation-were also identified by expressing Flag epitope-tagged
specific antibody (anti-P-Paka) against a peptide en-regions of ephexin with EphA4 in 293T cells and testing
compassing autophosphorylated serine residues 198for the presence of EphA4 in anti-FLAG immunoprecipi-
and 203 of Paka (Manser et al., 1997). In immunoblottates. In support of the findings from the yeast two-
experiments, anti-P-Paka recognized Paka when ex-hybrid assay, the DH-PH module of ephexin, but not
pressed in 293T cells only in the presence of a constitu-the SH3 domain, was found to coimmunoprecipitate with
tively active Rac1 mutant (RacV12), thus demonstratingEphA4 when coexpressed in 293T cells (Figure 3D). Taken
the specificity of this antibody toward phosphorylatedtogether, these data identify previously undefined func-
Pak (Figure 5A). Furthermore, the detection of Paka intions for the kinase domain of EphA receptors as well
the presence of RacV12 is eliminated when Paka serineas for the catalytic DH-PH module of a Dbl family GEF
residues 198 and 203 are mutated to alanine, demon-in mediating protein-protein interactions.
strating the site specificity of the antibody (J. Chernoff,
personal communication).
Ephexin Activates RhoA, Cdc42, and Rac1 To test whether ephexin can activate Pak, we per-
To determine the specific Rho GTPases on which ephe- formed immunoblot analysis with the anti-P-Paka anti-
xin can catalyze guanine nucleotide exchange, we uti- body on 293T cells coexpressing ephexin and Paka.
lized an in vitro assay that measures the ability of The expression of wild-type ephexin led to a robust
ephexin to induce the release of preloaded [3H]GDP from increase in Pak phosphorylation comparable to that ob-
various Rho family GTPases. In this assay, ephexin served with RacV12 expression (Figure 5A). The activa-
strongly activated RhoA and also significantly activated tion of Pak was dependent on the GEF activity of ephexin
Cdc42 (Figure 4A). We also assessed the nucleotide since a point mutation within the DH domain of ephexin
exchange activity of ephexin in neuronal extracts. Since (Q254A) that eliminates catalytic activity had no effect
Rho GTPases bind downstream effectors when in the on Pak phosphorylation (Figure 5B). The ability of
GTP bound state, GST fusions of these effectors can ephexin to activate Pak phosphorylation was also de-
be used to capture active Rho GTPases from cell lysates. pendent on active Rac1 since coexpression of a domi-
Thus, a GST fusion to the Rho binding domain (RBD) of nant-negative Rac1 (RacN17) blocked the ephexin-
rhotekin, a RhoA effector, can be used to assay levels induced increase in Pak phosphorylation (Figure 5A). We
of active RhoA (Ren et al., 1999), and a GST fusion to the also tested the ability of ephexin to activate endogenous
p21 binding domain (PBD) of Pak can be used to assay Pak in primary neuronal cultures. When cultured embry-
levels of active Cdc42 and Rac1 (Sander et al., 1998). onic cortical cells were infected with HSV-ephexin, a
Using this assay, we observed large increases in RhoA significant increase in Pak phosphorylation was ob-
and Cdc42 activities and small but reproducible in- served compared to uninfected neurons (Figure 5C).
creases in Rac1 activity in cultured embryonic cortical These results demonstrate that Pak is a downstream
neurons infected with a herpesvirus expressing ephexin target of activated ephexin.
(HSV-ephexin) (Figure 4B).
We also observed the effects of ephexin on the mor-
phology of fibroblasts, in which RhoA, Cdc42, and Rac1 Modulation of Ephexin Activity by EphA Receptors
The association of ephexin with EphA4 led us to investi-each elicit distinct morphological changes. Specifically,
RhoA induces stress fiber formation, Cdc42 filopodia gate whether EphA receptors might modulate ephexin
activity toward specific Rho GTPase signaling pathwaysextension, and Rac1 lamellipodia formation and mem-
brane ruffling (Nobes and Hall, 1995; Gauthier-Rouviere in a way that is consistent with the growth cone collaps-
ing activity of activated EphA receptors. The high sensi-et al., 1998). When expressed in REF-52 fibroblasts,
ephexin induced morphologic changes consistent with tivity of the anti-P-Pak antibody allowed us to measure
changes in the Rac1/Cdc42-Pak pathway in responsethe activation of RhoA, Cdc42, and Rac1 in 28%, 12%,
and 15% of transfected cells, respectively (Figures 4C to extracellular stimuli that were below the limits of de-
tection of the PBD pulldown assay (data not shown).and 5D). Because Cdc42 activation can lead to Rac1
activation in certain cellular contexts (Nobes and Hall, Cultured embryonic cortical cells were stimulated with
ephrin-A1 and cell lysates were subjected to immu-1995), the low level activation of Rac1 that we observe
in multiple assays of ephexin activity may reflect a direct noblot analysis with the anti-P-Paka antibody to assay
the activity of endogenous Rac1 and Cdc42 signalingactivation by ephexin or a secondary effect of activation
of Cdc42. Taken together, both in vitro and cell-based pathways. Ephrin-A1 stimulation led to a time-depen-
EphA Receptors Regulate Ephexin, a Novel Rho GEF
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Figure 4. Characterization of Ephexin GEF Activity
The guanine nucleotide exchange activity of ephexin was measured with (A) GDP release assays in vitro, (B) Rho GTPase effector pulldown
assays in neurons, and (C) F-actin morphology assays in ephexin-transfected REF-52 fibroblasts.
(A) The exchange activity of rat GST-ephexin (amino acids 67–620) fusion protein was measured as its ability to catalyze the release of [3H]GDP
from RhoA, Cdc42, or Rac1. Activity is expressed as the ratio of the amount of GDP retained on each Rho GTPase in the presence of ephexin
over the amount remaining in the absence of ephexin. Experiments were repeated at least three times, and each point was performed in
duplicate.
(B) The exchange activity of HSV-ephexin expressed in cultured E18 cortical neurons was measured by its ability to increase the levels of
activated RhoA, as detected by RBD pulldown (top panels), or to increase the levels of activated Rac1 or Cdc42, as detected by PBD pulldown.
Levels of Rac1, Cdc42, RhoA, and ephexin in the cell lysates were determined by immunoblotting (bottom panels).
(C) REF-52 cells were transfected with Flag-tagged ephexin and stained with anti-Flag followed by a FITC-conjugated secondary to detect
transfected cells and TRITC-phalloidin to detect F-actin. Transfected cells are indicated by arrows, and display RhoA-like (left), Cdc42-like
(middle), or Rac1-like (right) phenotypes.
dent inhibition of Pak phosphorylation that paralleled of the same cell lysates with an anti-Paka antibody indi-
cated that Paka levels remained constant upon HSV-the time course for Eph receptor activation, suggesting
that EphA receptor activation inhibits the Rac1/Cdc42- ephexin infection and ephrin-A1 treatment. These results
suggest that EphA receptor activation results in the inhi-Pak signaling pathway (Figure 5C). Since ephexin can
activate Pak, we asked whether Eph receptors might bition of ephexin activity toward the Rac1/Cdc42-Pak
signaling pathway.be inhibiting Pak through the modulation of ephexin
activity. Primary cultured cortical neurons were infected We also examined the ability of EphA4 receptors to
regulate ephexin activity in REF-52 fibroblasts. Ephexinwith HSV-ephexin and then treated with ephrin-A1 to
activate endogenous Eph receptors. The activation of expression induced the formation of stress fibers in ap-
proximately 25% of transfected cells, and lamellipodiaPak induced by HSV-ephexin as measured with the anti-
P-Paka antibody was significantly suppressed by treat- and filopodia in approximately 10%–20% of transfected
cells (Figure 5D). The morphologic effects induced byment with ephrin-A1 (Figure 5C). Immunoblot analysis
Cell
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Figure 5. Modulation of Ephexin Activity by EphA Receptors
(A) Characterization of a phosphorylation-specific Paka antibody, anti-P-Paka. 293T cells were transfected with Paka, ephexin, and/or Rac1
expression constructs and cell lysates immunoblotted with anti-P-Paka (top) or a total Pak antibody, anti-Paka (bottom).
(B) Characterization of a catalytically inactive mutant of ephexin, ephexinQA. 293T cells were transfected with empty vector, wild-type ephexin,
or ephexinQA, and levels of activated RhoA were measured by the RBD pulldown assay (top left). Paka phosphorylation in similarly transfected
cells was assayed by immunoblotting with anti-P-Paka (top right). Cell lysates were also assayed for the expression levels of wild-type ephexin
and ephexinQA (middle panels), RhoA levels (bottom left), or Paka (bottom right).
(C) Analysis of EphA receptor modulation of ephexin activity as measured with anti-P-Paka. Cortical neurons from E18 rat were infected with
HSV-ephexin or were left untreated (2). 12 hr after infection, the cells were treated with aggregated ephrin-A1-Fc for the indicated time points
and cell lysates were immunoblotted with anti-P-Paka to measure levels of Pak phosphorylation. Lysates were also immunoblotted with anti-
P-EphA to measure the state of EphA receptor activation, and with anti-Paka to measure the levels of Pak expression.
(D) EphA4 receptor modulation of ephexin activity toward Rho GTPases in REF-52 fibroblasts. REF-52 fibroblasts were transfected with wild-
type ephexin, ephexinQA, myc-tagged oncogenic Dbl, and/or wild-type EphA4. 24 hr after transfection, the cells were fixed and stained with
anti-ephexinN, anti-Myc, or anti-EphA4 antibodies to identify transfected cells, and with TRITC-phalloidin to visualize F-actin. All transfections
were repeated at least three times, and an average of 100 cells were examined each time.
ephexin were dependent on ephexin’s GEF activity since tors enhance the ability of ephexin to activate RhoA and
inhibit the ability of ephexin to activate Rac1 and Cdc42,the catalytically inactive Q254A mutant failed to elicit sig-
nificant morphologic effects in REF-52 cells (Figure 5D). thus resulting in a shift in the balance of Rho GTPase
activities.When expressed in REF-52 cells, EphA4 receptors in-
duced stress fiber formation in approximately 30% of
transfected cells (Figure 5D) and were constitutively ty- Ephexin Mediates Ephrin-Induced Growth
Cone Collapserosine phosphorylated at the important signaling tyro-
sines Y596 and Y602 (data not shown), suggesting that We next established an assay to directly address the role
of ephexin in mediating growth cone collapse activity ofthey were fully activated. The coexpression of EphA4
receptors with ephexin in REF-52 cells resulted in a sig- ephrin-A1 in purified RGCs. In RGCs cultured from both
E21 and P6 rat, ephrin-A1 induced dose-dependentnificant increase in the percentage of cells displaying
stress fibers and a marked decrease in the percentage of growth cone collapse that occurred in 80%–90% of growth
cones at maximal doses (Figures 6A and 6B). When wild-transfected cells with lamellipodia and filopodia (Figure
5D). In contrast, the coexpression of EphA4 receptors type ephexin was overexpressed in RGCs, the growth
cone collapse effect of ephrin-A1 was significantly en-with Dbl, another Rho family GEF, failed to modulate Dbl
activity in the REF-52 morphology assay (Figure 5D). hanced in ephexin-transfected cells as compared to
vector-transfected controls (Figure 6C). To inhibit theThese results demonstrate that activated EphA4 recep-
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Figure 6. Ephexin Functions in Growth Cone
Collapse Induced by Ephrin-A
(A) Ephrin-A1-Fc induces growth cone col-
lapse in cultures of purified rat RGCs. P6
RGCs were treated with either aggregating
antibody alone as a control (top) or with 5 mg/
ml of aggregated ephrin-A1-Fc (bottom) for
30 min and stained with Alexa 594-conju-
gated phalloidin.
(B) Dose-response curve of ephrin-A-induced
RGC growth cone collapse. Cultured purified
P6 or E21 RGCs were stimulated with aggre-
gated ephrin-A1-Fc at the indicated concen-
trations and the percentage of collapsed
growth cones counted. The mean percentage
collapse from two separate experiments,
each performed in duplicate, is shown.
(C and D) Overexpression of wild-type or mu-
tant ephexin alters growth cone responses to
ephrin-A. (C) P6 or E21 RGCs transfected with
the empty expression vector pA1, wild-type
ephexin, or ephexinQA-DH-PH were treated
with 5 mg/ml of aggregated ephrin-A1-Fc. At
each age, collapse rates were normalized to
those of pA1 transfectants. Asterisks mark
collapse rates significantly different (p , 0.05)
from pA1 transfectants. (D) The axon and
growth cones of a P6 RGC transfected with
ephexinQA-DH-PH (filled arrows) were de-
tected by visualizing coexpressed GFP (top).
Phalloidin staining of the same field shows
failure to collapse in response to aggregated
ephrin-A1-Fc (bottom). The open arrow indi-
cates an untransfected RGC.
activity of endogenous ephexin, we incorporated the of evidence suggest that ephexin couples EphA receptor
Q254A mutation into the DH-PH module of ephexin (QA- activation to modulation of Rho GTPase signaling that
DH-PH) and overexpressed it in RGCs. Since the GEF- leads to growth cone collapse. First, ephexin is expressed
inactive QA-DH-PH mutant maintains EphA4 receptor specifically in the CNS and is present during embryonic
binding activity (data not shown) and lacks the ability development in regions of the nervous system where
to bind to potentially important SH3 binding coregula- EphA receptors function to control axon guidance. Sec-
tors, this mutant could uncouple endogenous ephexin ond, ephexin associates directly with EphA receptors.
from EphA receptor regulation. When expressed in RGCs, Third, the activation of EphA receptors potentiates the
QA-DH-PH significantly inhibited ephrin-A1-induced ability of ephexin to activate RhoA yet leads to an inhibi-
growth cone collapse (Figures 6C and 6D). The expres- tion of ephexin activity toward Cdc42 and Rac1. Finally,
sion of wild-type or mutant ephexins did not significantly overexpression of ephexin leads to increased sensitivity
alter basal rates of collapse in unstimulated RGCs (data of RGCs to ephrin-A1-induced growth cone collapse,
not shown), demonstrating that the changes in collapse whereas a dominant-negative version of ephexin sup-
rates were dependent on EphA receptor activity. Taken presses ephrin-A1-induced collapse. Taken together,
together, the gain-of-function and loss-of-function ma- these findings suggest that ephexin plays an important
nipulations of ephexin in RGCs suggest that ephexin role in EphA receptor-initiated axon guidance repulsion.
is an important mediator of ephrin-A1-induced growth Rho family GTPases control the formation of distinct
cone collapse. actin-based structures in the growth cone, and have
been proposed as candidates for regulation by axon
guidance receptors. Forward migration of the growthDiscussion
cone may involve a balance between basal RhoA, Cdc42,
and Rac1 activities. Activated Cdc42 and Rac1 promoteEphA receptors and their ligands of the ephrin-A family
the extension of filopodia and lamellipodia, respectively,mediate short-range repulsion of axons during nervous
and activated RhoA generates contractile forces thatsystem development. However, the intracellular signal-
may be required for forward translocation of the growthing mechanisms engaged by EphA receptors that lead to
cone body (Schmitz et al., 2000). In contrast, growthlocalized actin rearrangement and growth cone collapse
cone collapse may result from elevated RhoA activityhave previously been poorly understood. Here we de-
concurrent with decreases in Cdc42 and Rac1 activity.scribe the cloning of ephexin, a novel member of the Dbl
family of GEFs that activates Rho GTPases. Several lines Increased RhoA-mediated contractility would lead to
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the withdrawal of the growth cone body, while reduced
Cdc42 and Rac1 activity would result in the retraction
of lamellipodia and filopodia from the leading edge of
the growth cone. Thus, it is possible that inhibitory axon
guidance receptors may induce growth cone collapse
by shifting the balance of Rho GTPase activities away
from Cdc42 and Rac1 and toward RhoA. Indeed, previ-
ous results have demonstrated that ephrin-A5 stimula-
tion of RGCs leads to the inhibition of Rac1 and activa-
tion of RhoA (Wahl et al., 2000), but have not elucidated
the molecular mechanisms by which EphA receptors
signal to Rho GTPases.
Our findings that EphA receptor activation leads to
an inhibition of ephexin activity toward Rac1 and Cdc42,
but an enhancement of ephexin activity toward RhoA,
suggest that the control of Rho GTPases by EphA recep-
tors is mediated in part by ephexin. In the absence of
ephrin-A1 stimulation, binding of ephexin to inactive
EphA receptors may serve to anchor ephexin at the cell
membrane of growth cones in a position to activate
RhoA, Cdc42, and Rac1 (Figure 7A). Under these condi-
tions, the net effect from ephexin activity and that of
other regulatory GEFs or GAPs would be growth cone
extension. When EphA receptors are activated through
contact with an ephrin-A-presenting cell surface,
ephexin activation of Cdc42 and Rac1 is inhibited,
whereas ephexin activation of RhoA is potentiated (Fig-
ure 7B). The reduction in Cdc42 and Rac1 activities
results in the retraction of lamellipodia and filopodia,
while the increase in RhoA activity leads to high levels
of contractile forces in the growth cone. Thus, EphA
receptor regulation of ephexin may play a role in modu-
lating Rho GTPases to orchestrate the collapse of the
growth cone. Control over the balance of Rho GTPase
activities may be a general mechanism by which axon
guidance factors and their receptors manipulate the actin Figure 7. A Model for How EphA and Ephexin May Locally Regulate
cytoskeleton to elicit attractive or repulsive growth cone Actin Dynamics in a Growth Cone during Axon Guidance
guidance effects. (A) In regions of the growth cone not in contact with ephrin-A,
For growth cones to respond to extracellular guidance ephexin is stably bound to EphA receptors at the membrane, where
ephexin contributes to the activation of RhoA, Cdc42, and Rac1.cues in a directional manner, guidance receptors must
The coordinate activation of these GTPases supports a basal leveltransduce highly localized signals to the actin cytoskele-
of actinomyosin contractility and filopodia and lamellipodia, whichton specifically in the region of the growth cone where
together generate forward movement.
receptor activation occurs. Our finding that ephexin (B) In regions of the growth cone in contact with ephrin-A, EphA
interacts directly with EphA4 receptors independent activation leads to a suppression of ephexin activity toward Rac1
of receptor kinase activity suggests a mechanism for and Cdc42 and to an enhancement of ephexin activity toward RhoA.
localized actin regulation by EphA receptors. Specifi- The suppression of Rac1 and Cdc42 may result in the local depoly-
merization of actin in filopodia and lamellipodia, while unopposedcally, EphA activation would result in the modulation of
actinomyosin contractility from potentiated RhoA activity may in-ephexin activity only at the site of ligand presentation,
duce localized withdrawal of filopodia and lamellipodia.while ephexin molecules in other regions of the growth
cone remain unaffected. Furthermore, because ephexin
is directly associated with EphA receptors, its down-
be an indirect effect of elevated RhoA activity, or vicestream effects on Rho GTPases may remain confined
versa, as has been previously suggested (Kozma et al.,to the vicinity of the activated receptors. Thus, ephexin
1997; Leeuwen et al., 1997). In addition, the access ofmay be modulated by EphA receptors to elicit local
ephexin to different Rho GTPases might be regulatedchanges in Rho GTPase activity and to induce spatially
by EphA receptors as a result of changes in Rho GTPaserestricted retraction of the growth cone at points of
subcellular localization, and this could contribute to thecontact with ephrin-A.
observed changes in Rho GTPase activities.The mechanism through which EphA receptors modu-
The EphA receptor-induced change in ephexin activitylate ephexin activity is currently not clear. One intriguing
might result from a posttranslational modification ofpossibility is that substrate specificity within the cata-
ephexin. One possibility is that EphA receptor activationlytic domain of ephexin can be differentially regulated
leads to changes in the phosphorylation state of ephexinto yield inhibitory effects toward some GTPases and
due to the activation of specific kinases or phospha-potentiating effects toward others. Alternatively, EphA4
inhibition of ephexin signaling to Rac1 and Cdc42 might tases. Ephexin might also be modified as a result of
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Expression PlasmidsEphA-induced regulation of the PI3-kinase signaling
The following constructs were received as gifts: Pak-a expressionpathway since EphA4 receptors bind to multiple PI3-
plasmid, Bruce Mayer; wild-type, dominant-negative, and constitu-kinase regulatory subunits (S. M. S., unpublished obser-
tive active Rac expression plasmids, Bruce Yanker (Children’s Hos-
vations), several Eph receptors are known to activate pital); EphA4 cDNA, John Flanagan (Harvard Medical School); full-
PI3-kinase (Pandey et al., 1994), and PI3-kinase lipid length mouse ephexin EST, Katsuyuki Hashimoto (National Institute
of Infectious Diseases, Tokyo); and pGEX-PBD and pGEX-RBD,products have been shown to regulate the activity of
Joan Brugge (Harvard Medical School). The myc-tagged Dbl con-Vav and aPIX, a Pak-interacting GEF (Han et al., 1998;
struct has been previously described (Olson et al., 1996). All otherYoshii et al., 1999). Alternatively, since the association
expression plasmids and viral plasmids described were constructedof EphA4 receptors occurs in the catalytic DH-PH do-
for this study using standard methods. Full sequences of plasmids
mains of ephexin, EphA modulation of ephexin might are available upon request.
occur through reversible steric or allosteric hindrance
of GEF activity. Further studies utilizing specific pharma-
Guanine Nucleotide Exchange Assays
cologic and dominant-negative reagents as well as more In vitro guanine nucleotide release assays were performed as de-
detailed structure-function analyses should help to elu- scribed elsewhere (Debant et al., 1996) using recombinant GST fu-
cidate the mechanism of regulation of ephexin by EphA sions with rat ephexin (amino acids 67–620) or with Rho GTPases
produced using standard procedures. To assay Cdc42 or Rac1 ac-receptors.
tivity in cells, 2 3 106 cells were harvested in GEF lysis buffer (20 mMIn summary, the experiments described here identify
Tris, pH 7.5; 20 mM MgCl2; 0.5% Nonidet P-40; 0.5% deoxycholicephexin as an important molecular link between EphA
acid; 150 mM NaCl; 1 mM dithiothreitol; 1 mM phenylmethyl sulfonyl
receptors and the Rho family of GTPases, and suggest fluoride; 0.5% aprotinin). Lysates were clarified by centrifugation and
a model for how EphA receptors may locally regulate incubated with 50 mg GST-PBD prebound to glutathione agarose
the actin cytoskeleton during axon guidance. Additional (Sigma) for 30 min at 48C. Samples were rinsed with GEF lysis buffer
and then immunoblotted with anti-Cdc42 or anti-Rac1. Assays mea-studies with specific inhibitors of ephexin and the ge-
suring RhoA activity were performed as described (Ren et al., 1999).netic disruption of ephexin will be required to determine
the role of ephexin in axon guidance and cell migration
Fibroblast Morphology Assaysevents during development.
REF-52 cells were maintained as described (Blangy et al., 2000) and
transfected using Lipofectamine (GibcoBRL). 24 hr after transfec-Experimental Procedures
tion, cells were fixed in 3.7% formaldehyde, permeabilized in 0.1%
Triton, and stained.Yeast Two-Hybrid Screening
The Interaction Trap yeast two-hybrid system was used as described
(Finley and Brent, 1996), with amino acids 570–986 of moues EphA4 Preparation of Ephrin-A1-Fc
as bait. An E14 rat spinal cord/dorsal root ganglia cDNA library The expression plasmid pJFE14-ephrin-A1-Fc (Davis et al., 1994)
consisting of 2 3 106 primary transformants and a TrkA bait plasmid was transfected into 293T cells, and ephrin-A1-Fc was purified from
were kindly provided by David Ginty (Johns Hopkins University). conditioned media with protein-A Sepharose as described (Davis
et al., 1994). Ephrin-A1-Fc was aggregated at 0.01 mg/ml (cortical
59-RACE neurons) or at 0.1 mg/ml (RGCs) 30 min prior to use with 0.09 mg/ml
Additional 59 sequences of rat ephexin were obtained using a 59- (cortical neurons) or 0.45 mg/ml (RGCs) goat anti-human Fcg anti-
RACE kit (GibcoBRL). Reverse transcription from P20 rat brain RNA body (Jackson Laboratories).
was performed with the 39 rat ephexin primer TATAGACCGAGAAG
TGATCA followed by consecutive PCR reactions with a universal 59
Growth Cone Collapseprimer and the nested 39 rat ephexin primers ATGTTCTCCTCCA
Retinal ganglion cells were purified and cultured as previously de-TGCGGTGTTC and CATCCAGGACATTGGAGAAGA.
scribed (Meyer-Franke et al., 1995). Expression plasmids were elec-
troporated into RGCs with a modified GenePulser (BioRad) using aAntibodies
variation of the microporation technique (Teruel et al., 1999). AfterThe anti-EphA4 antibody was raised against amino acids 909 to
1–2 days, aggregated ephrins were added to the cultures for 30 min,986 of mouse EphA4 fused to glutathione S-transferase (GST), as
fixed in 4% paraformaldehyde, stained with Alexa594-conjugatedpreviously described (Becker et al., 1995). Rabbit anti-P-EphA was
phalloidin (Molecular Probes), and scored for growth cone collapse.raised against the EphA3 peptide LRTY(p)VDPHRY(p)EDPTQ, in
which tyrosine residues 596 and 602 have been phosphorylated.
Anti-P-Paka was raised against the PAKa peptide PEHTKS(p)V Acknowledgments
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The following antibodies were raised against peptide sequences of The authors thank Pieter Dikkes for technical assistance with in situ
murine ephexin: anti-ephexinN, amino acids 93–108 (KSTLQEIET hybridization experiments, Wange Lu and Kathleen O’Connor for
RRQQDAE); SH3, amino acids 561–576 (FGERLHDQERGWFPSS); advice and reagents for Rho GTPase effector pulldown assays, Sara
and anti-ephexinC, amino acids 598–613 (HKMEDPQRSQNKDRRK). Vasquez for technical assistance with neuronal cell cultures, Jean-
Anti-Pak1N was a kind gift from Bruce Mayer, University of Connec- Michel Peyrin for assistance in establishing a growth cone collapse
ticut Health Center. The following antibodies are commercially avail- assay, Ben Barres for valuable advice, and members of the Green-
able: Rac1 (Transduction Laboratories), Cdc42 (Transduction Labo- berg lab for critical discussions and continued support. M. E. G.
ratories), RhoA (Santa Cruz), TuJ1 (Babco), and caveolin-1 (Santa Cruz). acknowledges the generous support of the F. M. Kirby Foundation to
the Division of Neuroscience. This work was supported by American
Cancer Society Fellowship PF-4391 and NIH Individual National Re-Membrane Isolation and Fractionation
Cellular membranes were prepared from P7 rats as described (Wys- search Service Award NS10070-02 (S. M. S.), a National Defense
Science and Engineering Graduate Fellowship (M. Z. L.), Nationalzynski and Sheng, 1999). Membranes were extracted with 1% Triton
X-100 for 1 hr at 48C and then centrifuged at 20,000 g for 10 min. Eye Institute grant RO1 EY11310 to Ben Barres and an NIH Medical
Scientist Training Program Fellowship (J. L. G.), National Institute ofThe supernatant, or the pellet after resuspension into the original
volume of TBS, was then boiled in sample buffer containing 0.1% Child Health and Human Development grant 1K08HD01384 (M. S.),
National Institute of Neurological Disorders and Stroke grant R01SDS and 5% b-mercaptoethanol, and subjected to SDS-PAGE and
immunoblotting. An equal beginning volume of membrane was directly NS35884 (G. C.), a Ligue Nationale pour la Recherche contre le
Cancer (e´quipe labelise´e) grant (A. D.), and Mental Retardation Re-boiled in sample buffer and electrophoresed in an adjacent lane.
Cell
244
search Center grant HD18655 and National Institutes of Health grant (1995). Differential expressions of the eph family of receptor tyrosine
kinase genes (sek, elk, eck) in the developing nervous system ofCA43855 (M. E. G.).
the mouse. Brain Res. Mol. Brain Res. 29, 325–335.
Received December 13, 2000; revised April 5, 2001. Nobes, C.D., and Hall, A. (1995). Rho, rac, and cdc42 GTPases
regulate the assembly of multimolecular focal complexes associated
with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53–62.References
Olson, M.F., Pasteris, N.G., Gorski, J.L., and Hall, A. (1996). Facio-
Bagrodia, S., and Cerione, R.A. (1999). Pak to the future. Trends genital dysplasia protein (FGD1) and Vav, two related proteins re-
Cell Biol. 9, 350–355. quired for normal embryonic development, are upstream regulators
of Rho GTPases. Curr. Biol. 6, 1628–1633.Becker, N., Gilardi-Hebenstreit, P., Seitanidou, T., Wilkinson, D., and
Charnay, P. (1995). Characterisation of the Sek-1 receptor tyrosine Pandey, A., Lazar, D.F., Saltiel, A.R., and Dixit, V.M. (1994). Activation
kinase. FEBS Lett. 368, 353–357. of the Eck receptor protein tyrosine kinase stimulates phosphatidyl-
inositol 3-kinase activity. J. Biol. Chem. 269, 30154–30157.Blangy, A., Vignal, E., Schmidt, S., Debant, A., Gauthier-Rouviere,
C., and Fort, P. (2000). TrioGEF1 controls Rac- and Cdc42-depen- Ren, X.D., Kiosses, W.B., and Schwartz, M.A. (1999). Regulation
dent cell structures through the direct activation of rhoG. J. Cell of the small GTP-binding protein Rho by cell adhesion and the
Sci. 113, 729–739. cytoskeleton. EMBO J. 18, 578–585.
Chan, A.M., McGovern, E.S., Catalano, G., Fleming, T.P., and Miki, T. Rodrigues, N.R., Theodosiou, A.M., Nesbit, M.A., Campbell, L., Tan-
(1994). Expression cDNA cloning of a novel oncogene with sequence dle, A.T., Saranath, D., and Davies, K.E. (2000). Characterization
similarity to regulators of small GTP-binding proteins. Oncogene 9, of Ngef, a novel member of the Dbl family of genes expressed
1057–1063. predominantly in the caudate nucleus. Genomics 65, 53–61.
Rothberg, K.G., Heuser, J.E., Donzell, W.C., Ying, Y.S., Glenney,Davis, S., Gale, N.W., Aldrich, T.H., Maisonpierre, P.C., Lhotak, V.,
J.R., and Anderson, R.G. (1992). Caveolin, a protein component ofPawson, T., Goldfarb, M., and Yancopoulos, G.D. (1994). Ligands
caveolae membrane coats. Cell 68, 673–682.for EPH-related receptor tyrosine kinases that require membrane
attachment or clustering for activity. Science 266, 816–819. Sander, E.E., van Delft, S., ten Klooster, J.P., Reid, T., van der Kam-
men, R.A., Michiels, F., and Collard, J.G. (1998). Matrix-dependentDebant, A., Serra-Pages, C., Seipel, K., O’Brien, S., Tang, M., Park,
Tiam1/Rac signaling in epithelial cells promotes either cell-cell ad-S.H., and Streuli, M. (1996). The multidomain protein Trio binds
hesion or cell migration and is regulated by phosphatidylinositolthe LAR transmembrane tyrosine phosphatase, contains a protein
3-kinase. J. Cell Biol. 143, 1385–1398.kinase domain, and has separate rac-specific and rho-specific gua-
nine nucleotide exchange factor domains. Proc. Natl. Acad. Sci. Schmitz, A.A., Govek, E.E., Bottner, B., and Van Aelst, L. (2000). Rho
USA 93, 5466–5471. GTPases: signaling, migration, and invasion. Exp. Cell Res. 261, 1–12.
Emanuelsson, O., Nielsen, H., Brunak, S., and von Heijne, G. (2000). Shu, H.K., Chang, C.M., Ravi, L., Ling, L., Castellano, C.M., Walter,
Predicting subcellular localization of proteins based on their N-ter- E., Pelley, R.J., and Kung, H.J. (1994). Modulation of erbB kinase
minal amino acid sequence. J. Mol. Biol. 300, 1005–1016. activity and oncogenic potential by single point mutations in the
glycine loop of the catalytic domain. Mol. Cell. Biol. 14, 6868–6878.Finley, R.L., and Brent, R. (1996). Interaction trap cloning with yeast.
In DNA Cloning—Expression Systems: A Practical Approach, D. Sicheri, F., Moarefi, I., and Kuriyan, J. (1997). Crystal structure of
Glover and B.D. Hames, eds. (Oxford, England: Oxford University the Src family tyrosine kinase Hck. Nature 385, 602–609.
Press), pp. 169–203. Teruel, M.N., Blanpied, T.A., Shen, K., Augustine, G.J., and Meyer,
Flanagan, J.G., and Vanderhaeghen, P. (1998). The ephrins and Eph T. (1999). A versatile microporation technique for the transfection
receptors in neural development. Annu. Rev. Neurosci. 21, 309–345. of cultured CNS neurons. J. Neurosci. Methods 93, 37–48.
Frisen, J., Holmberg, J., and Barbacid, M. (1999). Ephrins and their Wahl, S., Barth, H., Ciossek, T., Aktories, K., and Mueller, B.K. (2000).
Eph receptors: multitalented directors of embryonic development. Ephrin-A5 induces collapse of growth cones by activating Rho and
EMBO J. 18, 5159–5165. Rho kinase. J. Cell Biol. 149, 263–270.
Gauthier-Rouviere, C., Vignal, E., Meriane, M., Roux, P., Montcourier, Wahlberg, J.M., and Spiess, M. (1997). Multiple determinants direct
P., and Fort, P. (1998). RhoG GTPase controls a pathway that inde- the orientation of signal-anchor proteins: the topogenic role of the
pendently activates Rac1 and Cdc42Hs. Mol. Biol. Cell 9, 1379–1394. hydrophobic signal domain. J. Cell Biol. 137, 555–562.
Wilkinson, D.G. (2001). Multiple roles of Eph receptors and ephrinsHan, J., Luby-Phelps, K., Das, B., Shu, X., Xia, Y., Mosteller, R.D.,
in neural development. Nat. Rev. Neurosci. 2, 155–164.Krishna, U.M., Falck, J.R., White, M.A., and Broek, D. (1998). Role
of substrates and products of PI 3-kinase in regulating activation of Wu, C., Butz, S., Ying, Y., and Anderson, R.G. (1997). Tyrosine kinase
Rac-related guanosine triphosphatases by Vav. Science 279, 558–560. receptors concentrated in caveolae-like domains from neuronal
plasma membrane. J. Biol. Chem. 272, 3554–3559.Kozma, R., Sarner, S., Ahmed, S., and Lim, L. (1997). Rho family
GTPases and neuronal growth cone remodelling: relationship be- Wyszynski, M., and Sheng, M. (1999). Analysis of ion channel associ-
tween increased complexity induced by Cdc42Hs, Rac1, and acetyl- ated proteins. Methods Enzymol. 294, 371–385.
choline and collapse induced by RhoA and lysophosphatidic acid. Xu, W., Harrison, S.C., and Eck, M.J. (1997). Three-dimensional
Mol. Cell. Biol. 17, 1201–1211. structure of the tyrosine kinase c-Src. Nature 385, 595–602.
Leeuwen, F.N., Kain, H.E., Kammen, R.A., Michiels, F., Kranenburg, Yoshii, S., Tanaka, M., Otsuki, Y., Wang, D.Y., Guo, R.J., Zhu, Y.,
O.W., and Collard, J.G. (1997). The guanine nucleotide exchange Takeda, R., Hanai, H., Kaneko, E., and Sugimura, H. (1999). alphaPIX
factor Tiam1 affects neuronal morphology; opposing roles for the nucleotide exchange factor is activated by interaction with phospha-
small GTPases Rac and Rho. J. Cell Biol. 139, 797–807. tidylinositol 3-kinase. Oncogene 18, 5680–5690.
Manser, E., Huang, H.Y., Loo, T.H., Chen, X.Q., Dong, J.M., Leung,
T., and Lim, L. (1997). Expression of constitutively active alpha-PAK
reveals effects of the kinase on actin and focal complexes. Mol.
Cell. Biol. 17, 1129–1143.
Martoglio, B., and Dobberstein, B. (1998). Signal sequences: more
than just greasy peptides. Trends Cell Biol. 8, 410–415.
Meyer-Franke, A., Kaplan, M.R., Pfrieger, F.W., and Barres, B.A.
(1995). Characterization of the signaling interactions that promote
the survival and growth of developing retinal ganglion cells in cul-
ture. Neuron 15, 805–819.
Mori, T., Wanaka, A., Taguchi, A., Matsumoto, K., and Tohyama, M.
